Blood cancers, Myeloma
Results
Phase 3
This trial looked at lenalidomide, carfilzomib, bortezomib and vorinostat for people having intensive treatment for newly diagnosed myeloma. It was supported by Cancer Research UK.
Recruitment start: 25 May 2010
Recruitment end: 24 February 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Graham Jackson
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Leeds
This is Cancer Research UK trial number CRUK/09/014.
Last reviewed: 27 November 2019
CRUK internal database number: 3350
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
